BioSpace News Archive

BioForest

HDT Bio to Participate in World Vaccine Congress West Coast 2023

HDT Bio Corp. prevent infectious diseases and cancer, today announced its participation at the World Vaccine Congress West Coast 2023 in Santa Clara, California, from November 27 through 30, 2023.

November 16, 2023
·
3 min read
Pharm Country

Hyperfine, Inc. to Present at the Piper Sandler 35th Annual Healthcare Conference

Hyperfine, Inc. today announced plans to present at the upcoming Piper Sandler 35th Annual Healthcare Conference, in New York.

November 16, 2023
·
5 min read
BioMidwest

MicroVention Celebrates 10-Year Anniversary and Legacy of SOFIA™ Aspiration Catheters; More than 500,000 Procedures Performed Worldwide Across 170 Countries

MicroVention, Inc. is celebrating a decade of legacy innovation commemorating the anniversary of SOFIA™ and SOFIA™ Flow Plus Aspiration Catheters, with more than half a million worldwide procedures performed across 170 countries, and 30+ articles published globally since it was first introduced ten years ago.

November 16, 2023
·
5 min read
Cardiol Therapeutics Announces Study Results Presented at the 2023 Annual Meeting of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company”), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies

November 16, 2023
·
6 min read
American Aires and OMSLEEP Announce OEM Partnership with Launch of OM Sleep Mask

American Aires Inc. (CSE: WIFI) (OTC Pink: AAIRF) (“Aires” or the “Company”), a company focused on scientifically-proven EMF modulation technology

November 16, 2023
·
5 min read
Drug Development

Dermata to Begin Enrolling Patients in DMT310 Phase 3 Acne Clinical Program in December 2023 based on Agreement with FDA on the Phase 3 Protocols

Dermata Therapeutics, Inc. announces agreement with the U.S. Food and Drug Administration (FDA) on the DMT310 Phase 3 clinical protocols for the treatment of acne.

November 16, 2023
·
6 min read
Deals

Alzamend Neuro Regains Compliance with Nasdaq’s Minimum Bid Price Requirement

Alzamend Neuro, Inc. today announced that it has received a notification letter (the “ Compliance Notice ”) from the Listing Qualifications Staff of the Nasdaq Stock Market, LLC informing Alzamend that it has regained compliance with Nasdaq Listing Rule 5550(a)(2).

November 16, 2023
·
3 min read